LHRH-PE40

重组人促黄体激素释放激素-绿脓杆菌外毒素A融合蛋白

Report date: 2025/01/07 15:20:43

Base Information

Drug NameLHRH-PE40
Drug Alias NamerhLHRH-PE40比欧米赛
ClassificationBiologics > Protein drugs > Recombinant protein > Fusion protein
Mechanisms of ActionElongation factor 2 inhibitorsGonadotropin-releasing hormone receptor antagonists
TargetsElongation factor 2Gonadotropin-releasing hormone receptor
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPending (Phase 1 Clinical)
Highest Status in ChinaPending
Originator CompaniesJilin Yatai (Group) Co LtdChangchun Gene Engineering Medicine Research Institute Co Ltd
China Registration ClassClass 1 therapeutic biologic in China

Develop Information

Active CompaniesN/A
Inactive CompaniesJilin Yatai (Group) Co Ltd Pharmaceutical Research And Development CenterChangchun Gene Engineering Medicine Research Institute Co Ltd
Active IndicationsN/A
Inactive IndicationsNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A